• xxx

Professor Andrew Protheroe

University of Oxford Department of Oncology at the Oxford Cancer and Haematology Centre

Professor Andrew Protheroe is an Associate Professor of Uro-Oncology within the University of Oxford Department of Oncology at the Oxford Cancer and Haematology Centre. As a consultant medical oncologist, he has specialised in managing urological cancer at Oxford since 2001.  He qualified from St Thomas’s Hospital in London and after general medical training in London, trained in Oncology at St James’s University Hospital in Leeds.  His PhD was in tumour immunology and the research was based at Leeds and the National Cancer Institute in Amsterdam as an Honorary ICRF Clinical Research fellow funded by a Northern and Yorkshire research award.

He specialises in managing and overseeing patients with urological cancer providing specialised expert care to patients and their families with prostate cancer, kidney cancer, bladder cancer, testicular / germ cell cancer.  Between 2014 and 2021, he has been the co-clinical director for the NIHR Thames Valley and South Midlands Clinical Research Network. He has established and run successfully a large portfolio of clinical studies in urological cancer (some Phase I mainly phase II and III) locally, with national and international collaboration, both as CI and PI (mainly).  He has published over 130 peer-reviewed papers and is also the founding trustee of a urological cancer charity (UCARE).

UK Oncology Forum 2024

The UK Oncology Forum is only open to UK healthcare professionals. By choosing to continue to enter the UK Oncology Forum website, you are confirming that you are a UK healthcare professional.